Can copeptin and troponin T ratio predict final infarct size and myocardial salvage index in patients with ST-elevation myocardial infarction: A sub-study of the DANAMI-3 trial.

[1]  Marco Valgimigli,et al.  2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). , 2018, European heart journal.

[2]  A. Meyer,et al.  Release kinetics of high-sensitivity cardiac troponins I and T and troponin T upstream open reading frame peptide (TnTuORF) in clinically induced acute myocardial infarction , 2017, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[3]  L. Køber,et al.  Left Ventricular Hypertrophy Is Associated With Increased Infarct Size and Decreased Myocardial Salvage in Patients With ST‐Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention , 2017, Journal of the American Heart Association.

[4]  S. Bashir,et al.  Does plasma copeptin level at admission predict final infarct size in ST-elevation myocardial infarction. , 2016, International journal of cardiology.

[5]  H. Bøtker,et al.  The Third DANish Study of Optimal Acute Treatment of Patients with ST-segment Elevation Myocardial Infarction: Ischemic postconditioning or deferred stent implantation versus conventional primary angioplasty and complete revascularization versus treatment of culprit lesion only: Rationale and design , 2015, American heart journal.

[6]  M. Sebbane,et al.  A systematic review and collaborative meta-analysis to determine the incremental value of copeptin for rapid rule-out of acute myocardial infarction. , 2014, The American journal of cardiology.

[7]  F. Prinzen,et al.  Time-dependent degradation pattern of cardiac troponin T following myocardial infarction. , 2013, Clinical chemistry.

[8]  A. Mayr,et al.  Association of copeptin with myocardial infarct size and myocardial function after ST segment elevation myocardial infarction , 2013, Heart.

[9]  H. Bøtker,et al.  Final infarct size measured by cardiovascular magnetic resonance in patients with ST elevation myocardial infarction predicts long-term clinical outcome: an observational study. , 2013, European heart journal cardiovascular Imaging.

[10]  C. Hamm,et al.  Release kinetics of copeptin in patients undergoing transcoronary ablation of septal hypertrophy. , 2013, Clinical chemistry.

[11]  D. Yellon,et al.  Myocardial ischemia-reperfusion injury: a neglected therapeutic target. , 2013, The Journal of clinical investigation.

[12]  H. Bøtker,et al.  Measuring myocardial salvage. , 2012, Cardiovascular research.

[13]  B. Riou,et al.  Combined copeptin and troponin to rule out myocardial infarction in patients with chest pain and a history of coronary artery disease. , 2012, The American journal of emergency medicine.

[14]  H. Katus,et al.  Combined testing of high-sensitivity troponin T and copeptin on presentation at prespecified cutoffs improves rapid rule-out of non-ST-segment elevation myocardial infarction. , 2011, Clinical chemistry.

[15]  A. Denktas,et al.  Total ischemic time: the correct focus of attention for optimal ST-segment elevation myocardial infarction care. , 2011, JACC. Cardiovascular interventions.

[16]  A. Kastrati,et al.  Peak cardiac troponin-T level, scintigraphic myocardial infarct size and one-year prognosis in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction. , 2010, The American journal of cardiology.

[17]  N. Morgenthaler,et al.  Copeptin: a biomarker of cardiovascular and renal function. , 2010, Congestive heart failure.

[18]  G. Schuler,et al.  Prognostic significance and determinants of myocardial salvage assessed by cardiovascular magnetic resonance in acute reperfused myocardial infarction. , 2010, Journal of the American College of Cardiology.

[19]  S. Blankenberg,et al.  Copeptin improves early diagnosis of acute myocardial infarction. , 2010, Journal of the American College of Cardiology.

[20]  N. Morgenthaler,et al.  Incremental value of copeptin for rapid rule out of acute myocardial infarction. , 2009, Journal of the American College of Cardiology.

[21]  J. Fajadet,et al.  "Stent 4 Life" targeting PCI at all who will benefit the most. A joint project between EAPCI, Euro-PCR, EUCOMED and the ESC Working Group on Acute Cardiac Care. , 2009, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[22]  Stanley Chia,et al.  Utility of cardiac biomarkers in predicting infarct size, left ventricular function, and clinical outcome after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. , 2008, JACC. Cardiovascular interventions.

[23]  J. Struck,et al.  C-Terminal Provasopressin (Copeptin) as a Novel and Prognostic Marker in Acute Myocardial Infarction: Leicester Acute Myocardial Infarction Peptide (LAMP) Study , 2007, Circulation.

[24]  H. Katus,et al.  Cardiac troponin T at 96 hours after acute myocardial infarction correlates with infarct size and cardiac function. , 2006, Journal of the American College of Cardiology.

[25]  J. Burbach,et al.  Structure–Function Relationships of the Vasopressin Prohormone Domains , 1998, Cellular and Molecular Neurobiology.

[26]  Klaus Rasmussen,et al.  A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction. , 2003, The New England journal of medicine.

[27]  H. Katus,et al.  Troponin T concentrations 72 hours after myocardial infarction as a serological estimate of infarct size , 2002, Heart.

[28]  H. Schunkert,et al.  Evidence for a vasopressin system in the rat heart. , 1999, Circulation research.

[29]  A. Remppis,et al.  Intracellular compartmentation of cardiac troponin T and its release kinetics in patients with reperfused and nonreperfused myocardial infarction. , 1991, The American journal of cardiology.